Stocktwits on MSN
YD Bio Stock Rises On Entry Into US Eye Care Segment
The company also said that its Exovisse Artificial Tears have been developed in compliance with FDA mandates permitting nationwide over‑the‑counter distribution. ・YD Bio now plans to conduct a small ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果